, Volume 107, Issue 2–3, pp 195–202 | Cite as

Different neuroleptics show common dose and time dependent effects in quantitative field potential analysis in freely moving rats

  • W. Dimpfel
  • M. Spüler
  • K. Wessel
Original Investigations


Under the assumption that field potentials recorded from particular brain areas reflect the net balance of neurotransmitter activities, the dose- and time-dependent responses induced by intraperitoneal application of different neuroleptic drugs are quantified by spectral analysis of the electroencephalogram recorded from frontal cortex, hippocampus, striatum and reticular formation. The actions of haloperidol, chlorpromazine, clozapine, prothipendyl and thioridazine in general were characterized by increases of the spectral power in the alpha1 and beta range, at higher dosages also in the theta range. This observed pattern of changes is in line with the neuroleptic induced spectral changes reported in the literature for other animals and man. In the light of the already known effects of other psychoactive drugs on the frequency content of field potentials in the rat, it should now be possible to classify different drugs in terms of their clinical indication. With respect to the type of neurotransmitter control underlying the changes produced by various neuroleptics, it is quite obvious from the comparisons with the respective drug effects that dopamine-D1-receptor controlled transmission is not responsible for this action. On the basis of earlier findings a possible interaction between dopamin-D2 receptor or glutamatergic transmitter control is discussed.

Key words

Neuroleptics Rat Field potentials Telemetry Frequency analysis Electroencephalogram 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahrens H, Läuter J (1974) Mehrdimensionale Varianzanalyse. Akademia-Verlag, BerlinGoogle Scholar
  2. Bowen WD, Moses EL, Tolentino PJ, Walker JM (1990) Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D2-receptors. Eur J Pharmacol 177:111–118CrossRefPubMedGoogle Scholar
  3. Carlson M, Carlson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. TINS 13:272–276PubMedGoogle Scholar
  4. Dimpfel W, Spüler M (1990) Dizocilpine (MK-801), ketamine and phencyclidine: low doses affect brain field potentials in the freely moving rat in the same way as activation of dopaminergic transmission. Psychopharmacology 101:317–323Google Scholar
  5. Dimpfel W, Spüler M, Nickel B (1986) Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology 16:163–168PubMedGoogle Scholar
  6. Dimpfel W, Spüler M, Koch R, Schatton W (1987) Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 18:212–218PubMedGoogle Scholar
  7. Dimpfel W, Spüler M, Borbe HO (1988) Monitoring of the effects of antidepressant drugs in the freely moving rat by radioelectroencephalography (Tele-Stereo-EEG). Neuropsychobiology 19:116–120PubMedGoogle Scholar
  8. Dimpfel W, Schindler U, Spüler M (1989) Radioelectroencephalographic characterization of Tenilsetam (CAS 997), a putative nootropic compound, in the freely moving rat (Tele-Stereo-EEG). Drug Dev Res 18:217–227CrossRefGoogle Scholar
  9. Emilien G (1989) Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats. Neuropsychobiology 21:205–215PubMedGoogle Scholar
  10. Etevenon P, Pidoux B, Cottereau MJ, Peron-Magnang P, Zarifian E, Verdeaux G, Deniker P (1980) Quantitavie EEG analysis of high-dosage haloperidol effects in therapy-resistant schizophrenic patients. Adv Biol Psychiatry 4:175–187Google Scholar
  11. Fairchild MD, Jenden DJ, Mickey MR, Yale C (1980) The quantitative measurement of changes in EEG frequency spectra produced in the cat by sedative-hypnotics and neuroleptics. Electroencephalogr Clin Neurophysiol 49:382–390Google Scholar
  12. Fink M (1968) EEG classification of psychoacitve compounds in man: a review and theory of behavioral associations. In: Efron DH (ed) Psychopharmacology: a review of progress 1957–1967. US Government Printing Office, Washington DC, pp 497–507Google Scholar
  13. Reeß J, Grözinger B, Leibing U, Westphal KP, Diekmann V, Kornhuber HH (1988) Higher theta and alpha power in the EEG spectra with haloperidol; antagonizing effects of the anticholinergic biperidene. Psychopharmacology [suppl] 96:27.23.06Google Scholar
  14. Saletu B (1989) EEG imaging of brain activity in clinical psychopharmacology. In: Maurer K (ed) Topographic brain mapping of EEG and evoked potentials. Springer, Berlin Heidelberg New York, pp 482–506Google Scholar
  15. Sebban C, Tesolin B, Shvaloff A, Lemaitre-Guardiola B (1989)l-Fenfluramine and haloperidol in rats: a qEEG comparison. Psychopharmacology 98:131–138Google Scholar
  16. Westphal KP, Grözinger B, Diekmann V, Scherb W, Reeß J, Leibing U, Kornhuber HH (1990) Slower theta activity over the midfrontal cortex in schizophrenic patients. Acta Psychiatr Scand 81:132–138PubMedGoogle Scholar
  17. Yamamoto J (1985) Characteristics of the cortical and hippocampal EEG power spectra of rabbits during normal behavioral states and after administration of CNS acting drugs. Jpn J Pharmacol 37:227–234PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • W. Dimpfel
    • 1
  • M. Spüler
    • 1
  • K. Wessel
    • 2
  1. 1.Pro Science Private Research Institute GmbHLindenFederal Republic of Germany
  2. 2.Asta Medica AGFrankfurtFederal Republic of Germany

Personalised recommendations